Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Aditxt, Inc. stock logo
ADTX
Aditxt
$1.03
-5.5%
$1.34
$1.02
$21,400.00
$2.18M1.5857,112 shs217,306 shs
Bellicum Pharmaceuticals, Inc. stock logo
BLCM
Bellicum Pharmaceuticals
$0.07
$0.08
$0.06
$1.31
$727K1.3922,874 shs6,059 shs
GRI Bio, Inc. stock logo
GRI
GRI Bio
$1.32
+3.1%
$1.54
$1.10
$30.43
$3.30M-1.61279,703 shs279,984 shs
China SXT Pharmaceuticals, Inc. stock logo
SXTC
China SXT Pharmaceuticals
$1.70
+9.0%
$1.70
$0.95
$8.72
$197.25M1.2467,715 shs88,794 shs
7 AI Stocks to Invest in Today: Capitalizing on AI and Tech Trends in 2025 Cover

Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Aditxt, Inc. stock logo
ADTX
Aditxt
0.00%-13.45%-15.99%-53.81%-99.99%
Bellicum Pharmaceuticals, Inc. stock logo
BLCM
Bellicum Pharmaceuticals
0.00%0.00%0.00%0.00%0.00%
GRI Bio, Inc. stock logo
GRI
GRI Bio
0.00%-33.67%-8.33%-37.14%-89.86%
China SXT Pharmaceuticals, Inc. stock logo
SXTC
China SXT Pharmaceuticals
0.00%+6.92%-6.85%-25.44%-80.86%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Aditxt, Inc. stock logo
ADTX
Aditxt
N/AN/AN/AN/AN/AN/AN/AN/A
Bellicum Pharmaceuticals, Inc. stock logo
BLCM
Bellicum Pharmaceuticals
N/AN/AN/AN/AN/AN/AN/AN/A
GRI Bio, Inc. stock logo
GRI
GRI Bio
1.9994 of 5 stars
3.52.00.00.01.50.01.3
China SXT Pharmaceuticals, Inc. stock logo
SXTC
China SXT Pharmaceuticals
0.9118 of 5 stars
0.05.00.00.01.80.00.6
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Aditxt, Inc. stock logo
ADTX
Aditxt
0.00
N/AN/AN/A
Bellicum Pharmaceuticals, Inc. stock logo
BLCM
Bellicum Pharmaceuticals
0.00
N/AN/AN/A
GRI Bio, Inc. stock logo
GRI
GRI Bio
3.00
Buy$22.001,566.67% Upside
China SXT Pharmaceuticals, Inc. stock logo
SXTC
China SXT Pharmaceuticals
0.00
N/AN/AN/A

Current Analyst Ratings Breakdown

Latest GRI, ADTX, BLCM, and SXTC Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
6/11/2025
GRI Bio, Inc. stock logo
GRI
GRI Bio
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy
5/27/2025
GRI Bio, Inc. stock logo
GRI
GRI Bio
Ascendiant Capital Markets
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$40.00 ➝ $34.00
(Data available from 8/3/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Aditxt, Inc. stock logo
ADTX
Aditxt
$130K16.80N/AN/A($1.52) per share-0.68
Bellicum Pharmaceuticals, Inc. stock logo
BLCM
Bellicum Pharmaceuticals
$1.50M0.48N/AN/A$0.23 per share0.33
GRI Bio, Inc. stock logo
GRI
GRI Bio
N/AN/AN/AN/A$7.68 per shareN/A
China SXT Pharmaceuticals, Inc. stock logo
SXTC
China SXT Pharmaceuticals
$1.93M102.20N/AN/A$243.66 per share0.01
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Aditxt, Inc. stock logo
ADTX
Aditxt
-$34.45MN/A0.00N/A-46,082.47%-389.10%-84.71%8/18/2025 (Estimated)
Bellicum Pharmaceuticals, Inc. stock logo
BLCM
Bellicum Pharmaceuticals
-$24.97MN/A0.00N/AN/AN/A-157.93%N/A
GRI Bio, Inc. stock logo
GRI
GRI Bio
-$8.21M-$11.56N/AN/AN/AN/A-275.15%-168.22%8/12/2025 (Estimated)
China SXT Pharmaceuticals, Inc. stock logo
SXTC
China SXT Pharmaceuticals
-$3.10MN/A0.00N/AN/AN/AN/AN/A

Latest GRI, ADTX, BLCM, and SXTC Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/12/2025Q2 2025
GRI Bio, Inc. stock logo
GRI
GRI Bio
-$1.31N/AN/AN/AN/AN/A
5/15/2025Q1 2025
Aditxt, Inc. stock logo
ADTX
Aditxt
-$26,400.00-$8.12+$26,391.88-$8.12$0.43 million$0.00 million
5/15/2025Q1 2025
GRI Bio, Inc. stock logo
GRI
GRI Bio
-$4.08-$5.80-$1.72-$5.80N/AN/A
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Aditxt, Inc. stock logo
ADTX
Aditxt
N/AN/AN/AN/AN/A
Bellicum Pharmaceuticals, Inc. stock logo
BLCM
Bellicum Pharmaceuticals
N/AN/AN/AN/AN/A
GRI Bio, Inc. stock logo
GRI
GRI Bio
N/AN/AN/AN/AN/A
China SXT Pharmaceuticals, Inc. stock logo
SXTC
China SXT Pharmaceuticals
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Aditxt, Inc. stock logo
ADTX
Aditxt
N/A
0.08
0.08
Bellicum Pharmaceuticals, Inc. stock logo
BLCM
Bellicum Pharmaceuticals
N/A
3.04
3.04
GRI Bio, Inc. stock logo
GRI
GRI Bio
N/A
1.41
1.41
China SXT Pharmaceuticals, Inc. stock logo
SXTC
China SXT Pharmaceuticals
N/AN/AN/A

Institutional Ownership

CompanyInstitutional Ownership
Aditxt, Inc. stock logo
ADTX
Aditxt
15.54%
Bellicum Pharmaceuticals, Inc. stock logo
BLCM
Bellicum Pharmaceuticals
4.93%
GRI Bio, Inc. stock logo
GRI
GRI Bio
33.95%
China SXT Pharmaceuticals, Inc. stock logo
SXTC
China SXT Pharmaceuticals
5.02%

Insider Ownership

CompanyInsider Ownership
Aditxt, Inc. stock logo
ADTX
Aditxt
0.01%
Bellicum Pharmaceuticals, Inc. stock logo
BLCM
Bellicum Pharmaceuticals
10.30%
GRI Bio, Inc. stock logo
GRI
GRI Bio
0.13%
China SXT Pharmaceuticals, Inc. stock logo
SXTC
China SXT Pharmaceuticals
3.95%
CompanyEmployeesShares OutstandingFree FloatOptionable
Aditxt, Inc. stock logo
ADTX
Aditxt
602.12 million2.12 millionNo Data
Bellicum Pharmaceuticals, Inc. stock logo
BLCM
Bellicum Pharmaceuticals
139.72 million8.72 millionNot Optionable
GRI Bio, Inc. stock logo
GRI
GRI Bio
12.50 million2.49 millionNot Optionable
China SXT Pharmaceuticals, Inc. stock logo
SXTC
China SXT Pharmaceuticals
90116.03 million111.45 millionNot Optionable

Recent News About These Companies

China SXT Pharmaceuticals, Inc. (SXTC) - Yahoo Finance
China SXT Pharmaceuticals Inc Ordinary Shares
China SXT Pharmaceuticals regains compliance with Nasdaq
China SXT Pharmaceuticals Inc trading resumes
China SXT Pharmaceuticals Inc trading halted, volatility trading pause
China SXT Pharmaceuticals Inc trading halted, news pending

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Aditxt stock logo

Aditxt NASDAQ:ADTX

$1.03 -0.06 (-5.50%)
Closing price 08/1/2025 04:00 PM Eastern
Extended Trading
$1.04 +0.01 (+0.97%)
As of 08/1/2025 07:49 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Aditxt, Inc., a biotech company, engages in the development and commercialization of technologies that focus on improving the health through monitoring and modulating the immune systems. The company develops AditxtScore that allows individuals to understand, manage, and monitor their immune profiles in order to be informed about attacks on or by their immune system; and Apoptotic DNA Immunotherapy, a nucleic acid-based technology that utilizes an approach that mimics the way the body naturally induces tolerance to its tissues. It also develops ADI-100 for skin grafting, psoriasis, type 1 diabetes, and multiple sclerosis. Aditxt, Inc. has a license agreement with Loma Linda University and Leland Stanford Junior University. The company was formerly known as ADiTx Therapeutics, Inc. and changed its name to Aditxt, Inc. in July 2021. Aditxt, Inc. was incorporated in 2017 and is headquartered in Richmond, Virginia.

Bellicum Pharmaceuticals stock logo

Bellicum Pharmaceuticals NASDAQ:BLCM

Bellicum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering and developing novel cellular immunotherapies for the treatment of hematological cancers and solid tumors in the United States and internationally. The company's clinical product candidates include BPX-601, an autologous GoCAR-T product candidate, which is in Phase 1/2 clinical trials for the treatment of solid tumors expressing the prostate stem cell antigen. Its clinical product candidates also include BPX-603, an autologous dual-switch GoCAR-T product candidate, which is in Phase 1/2 clinical trials for the treatment of solid tumors expressing human epidermal growth factor receptor 2 antigen. It has collaboration and license agreements with Adaptimmune Therapeutics plc; Agensys, Inc.; BioVec Pharma, Inc.; ARIAD Pharmaceuticals, Inc.; and Baylor College of Medicine. Bellicum Pharmaceuticals, Inc. was incorporated in 2004 and is based in Houston, Texas.

GRI Bio stock logo

GRI Bio NASDAQ:GRI

$1.32 +0.04 (+3.13%)
As of 08/1/2025 04:00 PM Eastern

GRI Bio, Inc., a clinical-stage biopharmaceutical company, focuses on treating inflammatory, fibrotic, and autoimmune diseases in the United States. Its product pipeline comprises GRI-0621, which is in phase II clinical development for the treatment of idiopathic pulmonary fibrosis; GRI-0803 which is in phase I trial for the treatment of systematic lupus erythematosus; GRI-0124, which is in pre-clinical development for the treatment of primary sclerosing cholangitis; and GRI-0729 in pre-clinical development. The company also develops ADAIR and ADMIR for treatment of attention -deficit/hyperactivity disorder. GRI Bio, Inc. was formerly known as Glycoregimmune, Inc. GRI Bio, Inc. was founded in 2009 and is based in LA Jolla, California.

China SXT Pharmaceuticals stock logo

China SXT Pharmaceuticals NASDAQ:SXTC

$1.70 +0.14 (+8.97%)
Closing price 08/1/2025 03:59 PM Eastern
Extended Trading
$1.68 -0.02 (-1.47%)
As of 08/1/2025 07:48 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

China SXT Pharmaceuticals, Inc., a pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of traditional Chinese medicine pieces (TCMP) in China. The company offers advanced, fine, and regular TCMP products, and raw medicinal material, such as ChenXiang, SanQiFen, HongQi, SuMu, JiangXiang, CuYanHuSuo, XiaTianWu, LuXueJing, XueJie, ChaoSuanZaoRen, HongQuMi, ChuanBeiMu, HuangShuKuiHua, WuWeiZi, DingXiang, RenShen, QingGuo, JueMingZi, and ShaRen. It provides its products under the Suxuantang, Hui Chun Tang, and Tong Ren Tang brands. The company had an end-customer base of pharmaceutical companies, chain pharmacies, and hospitals in 10 provinces and municipalities in China. China SXT Pharmaceuticals, Inc. was founded in 2005 and is headquartered in Taizhou, China.